CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Canada

  • ID: 4370591
  • Report
  • Region: Canada
  • 228 pages
  • GlobalData
1 of 3
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Canada

Summary

Canada is a mature healthcare market, with a strong focus on pharma R&D and a high level of total healthcare expenditure that is 11% of its Gross Domestic Product (GDP). The increasing elderly population and its associated disease burden are expected to drive the growth of the pharmaceutical market, while government initiatives to reduce healthcare expenditure may limit growth. The value of the Canadian pharmaceutical market increased from US$19.6 Billion in 2009 to US$22.6 Billion in 2016, at a Compound Annual Growth Rate (CAGR) of 2%. The market value is expected to reach US$25 Billion in 2021.

In 2016, the value of the generic pharmaceutical market was US$6.16 Billion. In 2016, generic drugs accounted for 70.2% of prescriptions in Canada, compared with 89% in the US. However, generic drug sales account for only 22.4% of the US$25.1 Billion pharmaceutical market. The use of generic medicines saved nearly US$20 Billion for the government in 2016. The generics market is expected to continue to grow as the government promotes generics usage and as quality perception improves among patients.

In 2016 healthcare expenditure in Canada stood at US$228.1 Billion, an increase of US$44.8 Billion from 2015. In 2009, the healthcare expenditure as a percentage of GDP was 11.6%, which decreased to an estimated 11.1% in 2016. In 2009, health expenditure per capita was approximately US$4,497, which increased to an estimated US$6,299 in 2016. The increasingly elderly population and associated disease burden have been driving the growth of the pharmaceutical market. In 2016, the elderly population accounted for 17% of the total population, and this is expected to increase at a CAGR of 3.7% to 20% by 2021.

Canadian medical device market was valued at US$8.6 Billion in 2009, which increased to US$10.5 Billion in 2016, and it is expected to grow at a CAGR of 4.2% from US$11.4 Billion in 2017 to US$13.4 Billion in 2021. The main segments were ophthalmic devices, orthopedic devices, drug delivery devices, in vitro diagnostics and healthcare IT.

The report "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Canada" is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Canada.

In particular, this report provides the following analysis -
  • Provides an overview of the Canadian healthcare market and its key driving factors. It also gives a snapshot of the demographic, regulatory, and reimbursement landscape and healthcare infrastructure in Canada.
  • Provides an overview of the Canadian pharmaceutical and medical device markets, covering market size; the market shares of generic, Over-the-Counter (OTC) and biologic/biosimilar products; and the key drivers and barriers for the overall market. It also includes profiles of the major players, as well as SWOT assessments.
  • Covers the reimbursement and payer landscape, and includes details of the reimbursement process, insurance providers, pricing policies and drug price trends in Canada.
  • Provides detailed analysis of the political and economic environment in Canada, and analyses economic indicators, demographics, and healthcare infrastructure and expenditure.
  • Provides an overview of the opportunities for and challenges to growth in the Canadian healthcare market.
Companies mentioned in this report: Johnson & Johnson, Novartis, Teva, Apotex, Gilead.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Canada, and includes -
  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market (Johnson & Johnson, Novartis, Teva, Apotex and Gilead) and profiles and SWOT analyses of the major players in the medical device market (Johnson & Johnson, Medtronic, Baxter, Fresenius and Sonova)
  • An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
  • Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the Canadian healthcare market
Reasons to Buy

This report will enhance your decision-making capability by allowing you to -
  • Develop business strategies by understanding the trends shaping and driving the Canadian healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
  • Identify, understand, and capitalize on the opportunities and challenges in the Canadian healthcare market
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1.1 List of Tables
1.2 List of Figures

2. Executive Summary

3. Introduction
3.1 Report Guidance

4. Overview of the Pharmaceutical and Medical Device Markets
4.1 Pharmaceutical Market
4.1.1 Market Overview
4.1.2 Pharmaceutical Imports and Exports
4.1.3 Supply Channels
4.1.4 Market Segments
4.1.5 Overview of Major Therapeutic Areas
4.1.6 Overview of Major Drug Classes
4.1.7 Major Players
4.2 Medical Device Market
4.2.1 Market Overview
4.2.2 Overview of Top Five Segments
4.2.3 Major Players
4.3 Market Drivers and Barriers
4.3.1 Drivers
4.3.2 Barriers

5. Market Access
5.1 Reimbursement and Payer Landscape
5.1.1 Overview of Healthcare System
5.1.2 Drug Reimbursement Process
5.1.3 Medical Device and Diagnostics Reimbursement Process
5.1.4 Overview of Insurance Providers
5.1.5 Patient Share in Healthcare Spending
5.1.6 Price Trend in Healthcare Services
5.1.7 Pricing Policies
5.2 Regulatory Landscape
5.2.1 Overview of Regulatory Agencies
5.2.2 Market Authorization Procedure for Pharmaceutical Products
5.2.3 Market Authorization Procedure for Medical Devices
5.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing
5.2.5 Licensing Process for Pharmaceutical Exports and Imports
5.2.6 Intellectual Property Rights
5.2.7 Clinical Trial Regulations
5.2.8 Pharmacy Regulations
5.2.9 Labeling and Packaging Regulations

6. Country Analysis
6.1 Political Environment
6.1.1 Political Structure
6.1.2 Analysis of the Current Political Environment
6.1.3 Healthcare Policy Initiatives
6.2 Economic Landscape
6.3 Economic Indicators
6.3.1 Gross Domestic Product
6.3.2 Gross National Income
6.3.3 Inflation
6.3.4 Currency Exchange Rate
6.3.5 Foreign Direct Investment
6.3.6 Foreign Exchange Reserves
6.3.7 Trade Balance
6.3.8 General Government Structural Balance
6.3.9 General Government Net Debt
6.3.10 Major Industries
6.4 Demographics
6.4.1 Population
6.4.2 Urban-Rural Share
6.4.3 Distribution by Age Group
6.4.4 Birth Rate
6.4.5 Mortality
6.4.6 Causes of Mortality
6.4.7 Health Status by Gender and Age
6.4.8 Education and Literacy
6.4.9 Employment
6.4.10 Disease Burden
6.5 Healthcare Infrastructure
6.5.1 Healthcare Facilities
6.5.2 Healthcare Parameters
6.5.3 Environmental Health
6.5.4 Healthcare Personnel
6.6 Healthcare Expenditure
6.6.1 Overview
6.6.2 Public-Private Sector Share
6.6.3 Major Components of Healthcare Spending
6.6.4 Spending in Science and Technology Research and Development
6.7 Trade Associations
6.7.1 Canadian Pharmacists Association (CPhA)
6.7.2 Canadian Association of Professional Regulatory Affairs
6.7.3 Canadian Society for Hospital Pharmacists
6.7.4 Canadian Generic Pharmaceutical Association
6.8 Trade Fairs

7. Opportunities and Challenges
7.1 Opportunities
7.2 Challenges

8. Appendix
8.1 Abbreviations
8.2 Bibliography
8.3 Research Methodology
8.3.1 Coverage
8.3.2 Secondary Research
8.3.3 Forecasts
8.3.4 Expert Panel
8.4 Contact Us
8.5 Disclaimer

1.1 List of Tables
Table 1: Pharmaceutical Market, Canada, Revenue ($bn), 2009-2016
Table 2: Pharmaceutical Market, Canada, Revenue Forecast ($bn), 2017-2021
Table 3: Pharmaceutical Market, Canada, Pharmaceutical Spending (% of health spending), 2009-2015
Table 4: Pharmaceutical Market, Canada, Pharmaceutical Exports and Imports ($bn), 2009-2016
Table 5: Pharmaceutical Market, Canada, Average Price Generic Drug vs. Branded Drug, 2009-2016
Table 6: Pharmaceutical Market, Biologics, Canada, Approved Biologics, 2016
Table 7: Pharmaceutical Market, Canada, Over-the-Counter Drug Market Revenue ($bn), 2009-2016
Table 8: Pharmaceutical Market, Canada, Sales of Patented Drug Products by Major Therapeutic Class ($bn), 2015
Table 9: Pharmaceutical Market, Canada, Major Drug Classes by Annual Growth Rate (%), 2012-2015
Table 10: Pharmaceutical Market, Johnson & Johnson, Canada, Major Products, 2016
Table 11: Pharmaceutical Market, Johnson & Johnson, Planned Filings, 2017-2020
Table 12: Pharmaceutical Market, Novartis, Canada, Major Products, 2017
Table 13: Pharmaceutical Market, Novartis, Planned Filings, 2017-2020
Table 14: Pharmaceutical Market, Teva, Late-Stage Pipeline, 2017
Table 15: Pharmaceutical Market, Gilead, Major Products, 2017
Table 16: Pharmaceutical Market, Gilead, Global, Late-Stage Pipeline, 2017
Table 17: Medical Device Market, Canada, Revenue ($bn), 2009-2016
Table 18: Medical Device Market, Canada, Revenue Forecast ($bn), 2017-2021
Table 19: Medical Device Market, Canada, Revenue ($bn) and Market Share ($bn) by Segment, 2016
Table 20: Orthopedic Devices Market, Canada, Revenue ($bn), 2009-2016
Table 21: Orthopedic Devices Market, Canada, Revenue ($m) and Market Share (%) of Major Companies, 2016
Table 22: Ophthalmic Devices Market, Canada, Revenue ($bn), 2009-2016
Table 23: Ophthalmic Devices Market, Canada, Revenue ($m) and Market Share (%) of Major Companies, 2016
Table 24: Drug Delivery Devices Market, Canada, Revenue ($bn), 2009-2016
Table 25: Ophthalmic Devices Market, Canada, Revenue ($m) and Market Share (%) of Major Companies, 2016
Table 26: Cardiovascular Devices Market, Canada, Revenue of Major Players ($m), 2009-2016
Table 27: IVD Market, Canada, Revenue ($m) and Market Share (%) of Major Companies, 2015
Table 28: IVD Market, Canada, Revenue ($bn), 2009-2016
Table 29: Healthcare IT Market, Canada, Revenue ($m) and Market Share (%) of Major Companies, 2016
Table 30: Medical Device Market, Canada, Revenue ($m) of Major Companies, 2012
Table 31: Medical Device Market, Johnson & Johnson, Major Medical Device Sales, 2016
Table 32: Medical Device Market, Medtronic, Major Products, 2016
Table 33: Medical Device Market, Baxter, Global, Major Products, 2017
Table 34: Medical Device Market, Fresenius Medical Care, Global, Major Products, 2016
Table 35: Medical Device Market, Sonova, Global, Major Products, 2017
Table 36: Market Access, Canada, Out-of-Pocket Expenditure (% of total expenditure on health), 2009-2016
Table 37: Market Access, Canada, Annual Rate of Change (%), Patented Medicines Price Index, 2009-2015
Table 38: Market Access, Canada, Average Ratio of International Price to Canadian Price, 2009-2015
Table 39: Market Access, Target Review Times for New Drug Submissions, Canada, 2016
Table 40: Market Access, Classes of Medical Devices, 2016
Table 41: Economic Indicators, Canada, Gross Domestic Product per Capita ($), 2009-2016
Table 42: Economic Indicators, Canada, Gross Domestic Product per Capita Forecast ($), 2017-2021
Table 43: Economic Indicators, Canada, Gross Domestic Product Annual Growth (%), 2009-2016
Table 44: Economic Indicators, Canada, Gross Domestic Product Annual Growth Forecast (%), 2017-2021
Table 45: Economic Indicators, Canada, Gross National Income per Capita ($), 2009-2016
Table 46: Economic Indicators, Canada, Average Consumer Price Index, 2009-2016
Table 47: Economic Indicators, Canada, Average Consumer Price Annual Change (%), 2009-2016
Table 48: Economic Indicators, Canada, Currency Exchange Rate (CAD per $), 2009-2016
Table 49: Economic Indicators, Canada, Foreign Direct Investment ($bn), 2009-2015
Table 50: Economic Indicators, Canada, Foreign Exchange Reserves ($bn), 2009-2016
Table 51: Economic Indicators, Canada, Imports of Goods and Services ($bn), 2009-2016
Table 52: Economic Indicators, Canada, Exports of Goods and Services ($bn), 2009-2016
Table 53: Economic Indicators, Canada, Government Structural Balance ($bn), 2009-2016
Table 54: Economic Indicators, Canada, General Government Net Debt ($bn), 2009-2016
Table 55: Economic Indicators, Canada, Major Industries by Gross Value Added (percentage of GDP), 2016
Table 56: Demographics, Canada, Population (million), 2009-2016
Table 57: Demographics, Canada, Population (million), 2017-2021
Table 58: Demographics, Canada, Urban-Rural Population Share (%), 2009-2016
Table 59: Demographics, Canada, Population Distribution by Age Group (%), 2009-2016
Table 60: Demographics, Canada, Population Distribution by Age Group Forecast (%), 2017-2021
Table 61: Demographics, Canada, Births (per 1,000 population), 2009-2015
Table 62: Demographics, Canada, Mortality (per 1,000 population), 2009-2015
Table 63: Demographics, Canada, Major Causes of Mortality, 2015
Table 64: Demographics, Canada, Infant Mortality (per 1,000 live births), 2009-2016
Table 65: Demographics, Canada, Immunization Rate (%), 2009-2016
Table 66: Demographics, Canada, Major Causes of Male Mortality, 2015
Table 67: Demographics, Canada, Major Causes of Female Mortality, 2015
Table 68: Demographics, Canada, Gender Ratio (M/F), 2009-2016
Table 69: Demographics, Canada, Life Expectancy at Birth (years), 2009-2016
Table 70: Demographics, Canada, Part-Time and Full-Time University Students (‘000), 2009-2015
Table 71: Demographics, Canada, Unemployment Rate (%), 2009-2016
Table 72: Demographics, Canada, Most Frequently Diagnosed Diseases (‘000), 2015
Table 73: Demographics, Canada, Disability-Adjusted Life Years by Major Disease (‘000), 2015
Table 74: Healthcare Infrastructure, Canada, Number of Hospitals, 2009-2015
Table 75: Healthcare Infrastructure, Canada, Diagnostic Equipment (per million population), 2009-2015
Table 76: Healthcare Infrastructure, Canada, Hospital Beds (per 1,000 population), 2009-2015
Table 77: Healthcare Infrastructure, Canada, Acute Care Hospital Beds (per 1,000 population), 2009-2015
Table 78: Healthcare Infrastructure, Canada, Psychiatric Hospital Beds (per 1,000 population), 2009-2015
Table 79: Healthcare Infrastructure, Canada, PM2.5 (µg per m3), 2009-2015
Table 80: Healthcare Infrastructure, Canada, CO2 Emissions (million tons), 2009-2015
Table 81: Healthcare Infrastructure, Canada, Physicians (per 1,000 population), 2009-2015
Table 82: Healthcare Infrastructure, Canada, Dentists, 2009-2015
Table 83: Healthcare Infrastructure, Canada, Pharmacists, 2009-2015
Table 84: Healthcare Infrastructure, Canada, Nurses (per 1,000 population), 2009-2015
Table 85: Healthcare Expenditure, Canada, Healthcare Expenditure as Percentage of GDP (%), 2009-2016
Table 86: Healthcare Expenditure, Canada, Healthcare Expenditure ($bn), 2014-2019
Table 87: Healthcare Expenditure, Canada, Public-Private Share (%), 2009-2015
Table 88: Healthcare Expenditure, Canada, Major Components of Healthcare Spending (%), 2014
Table 89: Healthcare Expenditure, Canada, Share of Financing Agents (%), 2016
Table 90: Healthcare Expenditure, Canada, R&D Expenditure as Percentage of GDP (%), 2009-2015
Table 91: Healthcare Expenditure, Canada, Major Healthcare Trade Fairs, 2017

1.2 List of Figures
Figure 1: Pharmaceutical Market, Canada, Revenue ($bn), 2009-2021
Figure 2: Medical Device Market, Canada, Revenue ($bn), 2009-2021
Figure 3: Country Profile, Canada, 2017
Figure 4: Pharmaceutical Market, Canada, Revenue ($bn), 2009-2016
Figure 5: Pharmaceutical Market, Canada, Revenue Forecast ($bn), 2017-2021
Figure 6: Pharmaceutical Market, Canada, Pharmaceutical Spending as Percentage of Health Spending (%), 2009-2015
Figure 7: Pharmaceutical Market, Canada, Pharmaceutical Exports and Imports ($bn), 2009-2016
Figure 8: Pharmaceutical Market, Canada, Supply Channels, 2016
Figure 9: Pharmaceutical Market, Canada, Average Price Generic Drug vs. Branded Drug, 2009-2016
Figure 10: Pharmaceutical Market, Canada, Over-the-Counter Drug Market Revenue ($bn), 2009-2016
Figure 11: Pharmaceutical Market, Canada, Sales of Patented Drug Products by Major Therapeutic Class, 2015
Figure 12: Pharmaceutical Market, Canada, Major Drug Classes by Annual Growth Rate (%), 2012-2015
Figure 13: Medical Device Market, Canada, Revenue ($bn), 2009-2016
Figure 14: Medical Device Market, Canada, Revenue Forecast ($bn), 2017-2021
Figure 15: Medical Device Market, Canada, Revenue by Segment ($bn), 2016
Figure 16: Orthopedic Devices Market, Canada, Revenue ($bn), 2009-2016
Figure 17: Orthopedic Devices Market, Canada, Market Share of Major Players (%), 2016
Figure 18: Ophthalmic Devices Market, Canada, Revenue ($bn), 2009-2016
Figure 19: Ophthalmic Devices Market, Canada, Market Share of Major Players (%), 2016
Figure 20: Drug Delivery Devices Market, Canada, Revenue ($bn), 2009-2016
Figure 21: Drug Delivery Devices Market, Canada, Market Share of Major Players (%), 2016
Figure 22: In Vitro Diagnostics Market, Canada, Revenue ($bn), 2009-2016
Figure 23: In Vitro Diagnostics Market, Canada, Market Share of Major Players (%), 2015
Figure 24: Healthcare IT Market, Canada, Revenue ($bn), 2009-2016
Figure 25: Healthcare IT Market, Canada, Market Share of Major Companies (%), 2016
Figure 26: Medical Device Market, Canada, Revenue of Major Companies ($m), 2012
Figure 27: Pharmaceutical Market, Canada, Drivers and Barriers, 2017
Figure 28: Market Access, Canada, Reimbursement Process, 2017
Figure 29: Market Access, Canada, Medical Device and Diagnostics Reimbursement Process, 2017
Figure 30: Market Access, Canada, Out-of-Pocket Expenditure (% of total expenditure on health), 2009-2016
Figure 31: Market Access, Canada, Annual Rate of Change (%), Patented Medicines Price Index, 2009-2015
Figure 32: Market Access, Canada, Average Ratio of International Price to Canadian Price, 2009-2015
Figure 33: Health Products and Food Branch, Organization Chart, Canada, 2015
Figure 34: New Drug Approval Process, Canada, 2017
Figure 35: Patent Approval Process, Canada, 2015
Figure 36: Clinical Trial Regulation Process, Canada, 2016
Figure 37: Economic Indicators, Canada, Gross Domestic Product per Capita ($), 2009-2016
Figure 38: Economic Indicators, Canada, Gross Domestic Product per Capita Forecast ($), 2017-2021
Figure 39: Economic Indicators, Canada, Gross Domestic Product Annual Growth (%), 2009-2016
Figure 40: Economic Indicators, Canada, Gross Domestic Product Annual Growth Forecast (%), 2017-2021
Figure 41: Economic Indicators, Canada, Gross National Income per Capita ($), 2009-2016
Figure 42: Economic Indicators, Canada, Average Consumer Price Index, 2009-2016
Figure 43: Economic Indicators, Canada, Average Consumer Price Annual Change (%), 2009-2016
Figure 44: Economic Indicators, Canada, Currency Exchange Rate (CAD per $), 2009-2016
Figure 45: Economic Indicators, Canada, Foreign Direct Investment ($bn), 2009-2015
Figure 46: Economic Indicators, Canada, Foreign Exchange Reserves ($bn), 2009-2016
Figure 47: Economic Indicators, Canada, Imports of Goods and Services ($bn), 2009-2016
Figure 48: Economic Indicators, Canada, Exports of Goods and Services ($bn), 2009-2016
Figure 49: Economic Indicators, Canada, Government Structural Balance ($bn), 2009-2016
Figure 50: Economic Indicators, Canada, General Government Net Debt ($bn), 2009-2016
Figure 51: Economic Indicators, Canada, Major Industries by Gross Value Added (percentage of GDP), 2016
Figure 52: Demographics, Canada, Population (million), 2009-2016
Figure 53: Demographics, Canada, Population (million), 2017-2021
Figure 54: Demographics, Canada, Urban-Rural Population Share (%), 2009-2016
Figure 55: Demographics, Canada, Population Distribution by Age Group (%), 2009-2016
Figure 56: Demographics, Canada, Population Distribution by Age Group Forecast (%), 2017-2021
Figure 57: Demographics, Canada, Births (per 1,000 population), 2009-2015
Figure 58: Demographics, Canada, Mortality (per 1,000 population), 2009-2015
Figure 59: Demographics, Canada, Major Causes of Mortality, 2015
Figure 60: Demographics, Canada, Infant Mortality (per 1,000 live births), 2009-2016
Figure 61: Demographics, Canada, Immunization Rate (%), 2009-2016
Figure 62: Demographics, Canada, Major Causes of Male Mortality, 2015
Figure 63: Demographics, Canada, Major Causes of Female Mortality, 2015
Figure 64: Demographics, Canada, Gender Ratio (M/F), 2009-2016
Figure 65: Demographics, Canada, Life Expectancy at Birth (years), 2009-2016
Figure 66: Demographics, Canada, Part-Time and Full-Time University Students (‘000), 2009-2015
Figure 67: Demographics, Canada, Unemployment Rate (%), 2009-2016
Figure 68: Demographics, Canada, Patients (‘000s), 2015-2016
Figure 69: Demographics, Canada, Disability-Adjusted Life Years by Major Disease (‘000), 2015
Figure 70: Healthcare Infrastructure, Canada, Number of Hospitals, 2009-2015
Figure 71: Healthcare Infrastructure, Canada, Diagnostic Equipment (per million population), 2009-2015
Figure 72: Healthcare Infrastructure, Canada, Hospital Beds (per 1,000 population), 2009-2015
Figure 73: Healthcare Infrastructure, Canada, Acute Care Hospital Beds (per 1,000 population), 2009-2015
Figure 74: Healthcare Infrastructure, Canada, Psychiatric Hospital Beds (per 1,000 population), 2009-2015
Figure 75: Healthcare Infrastructure, Canada, PM2.5 (µg per m3), 2009-2015
Figure 76: Healthcare Infrastructure, Canada, CO2 Emissions (million tons), 2009-2015
Figure 77: Healthcare Infrastructure, Canada, Physicians, 2009-2015
Figure 78: Healthcare Infrastructure, Canada, Dentists, 2009-2015
Figure 79: Healthcare Infrastructure, Canada, Pharmacists, 2009-2015
Figure 80: Healthcare Infrastructure, Canada, Nurses, 2009-2015
Figure 81: Healthcare Expenditure, Canada, Healthcare Expenditure as Percentage of GDP (%), 2009-2016
Figure 82: Healthcare Expenditure, Canada, Healthcare Expenditure ($bn), 2014-2019
Figure 83: Healthcare Expenditure, Canada, Public-Private Share (%), 2009-2015
Figure 84: Healthcare Expenditure, Canada, Major Components of Healthcare Spending (%), 2014
Figure 85: Healthcare Expenditure, Canada, Share of Financing Agents (%), 2016
Figure 86: Healthcare Expenditure, Canada, R&D Expenditure as Percentage of GDP (%), 2009-2015
Figure 87: Healthcare Market, Canada, Opportunities and Challenges, 2017
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll